Welcome to our dedicated page for Amn Healthcare news (Ticker: AMN), a resource for investors and traders seeking the latest updates and insights on Amn Healthcare stock.
AMN Healthcare Services reports developments in healthcare workforce solutions and staffing services for healthcare organizations across the United States. Recurring updates cover quarterly results, earnings calls, revenue trends, gross margin, cash flow, debt, and outlook commentary across Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions.
Company news also tracks travel nurse staffing, labor disruption staffing, allied staffing, international nurse placement, search, managed service provider activity, language services, workforce technology, and market demand from healthcare systems. AMN's common stock trades on the New York Stock Exchange under the symbol AMN.
AMN Healthcare (AMN) elected Eric Palmer to its Board of Directors, effective May 1, 2026. Palmer brings over 25 years of leadership in healthcare services, benefits and insurance.
He previously served as CEO of Evernorth Health Services, leading revenue to over $200 billion, and as CFO of Cigna, where he helped drive the Express Scripts acquisition.
AMN Healthcare (NYSE: AMN) reported Q1 2026 revenue of $1.378 billion and adjusted EBITDA of $166.1 million. GAAP diluted EPS was $1.59; adjusted diluted EPS was $2.10. Nurse and Allied revenue was $1.127 billion, and labor disruption contributed $722 million of revenue.
Cash from operations was $562 million, quarter-end cash was $561 million, and total debt was $750 million. Q2 2026 revenue guidance is $620–$635 million with adjusted EBITDA margin of 6.7%–7.2%.
AMN Healthcare (NYSE: AMN) will report first quarter 2026 results and host a conference call on Thursday, May 7, 2026 at 5:00 p.m. ET. The company expects to issue an earnings release at approximately 4:15 p.m. ET the same day.
A live webcast and telephone participation are available via registration on the investor relations website, with a replay posted after the call. In 2025, AMN’s healthcare professionals reached over 13 million patients across more than 2,300 healthcare systems, including 93% of top systems.
AMN Healthcare (NYSE:AMN) reports a sharp confidence divide: nearly three-quarters of healthcare executives expect their own organizations to be as strong or stronger in 2026, while 52% expect the overall industry to fare worse. The 2026 B.E. Smith survey of 703 executives highlights rising demand for AI leadership (63% prioritize AI strategy) and persistent gaps in succession planning, clinician engagement, recruiting, and promotion pathways.
Key metrics: AI strategy 63%, clinician adoption 48%, data infrastructure 41%, promotion-track 21%, intent-to-leave within one year 35%.
AMN Healthcare (NYSE: AMN) reported Q4 2025 revenue of $748.2M and GAAP loss of ($0.20) per share; adjusted EPS was $0.22. Full‑year revenue was $2.730B (down 8%) with a net loss of ($95.7M). Cash flow from operations totaled $269M for 2025 and the company reduced total debt by $285M. First‑quarter 2026 guidance assumes ~$600M of labor disruption revenue, driving Q1 consolidated revenue guidance of $1.225–$1.240B.
AMN Healthcare (NYSE: AMN) reported Q4 2025 revenue of $748.2 million (up 2% YoY; +18% sequential) and GAAP loss of ($0.20) per share. Adjusted EPS was $0.22 and adjusted EBITDA was $54.5 million. Full-year 2025 revenue was $2.730 billion (down 8% YoY) with adjusted EPS of $1.36. Cash flow from operations was $76 million for Q4 and $269 million for the year; total debt ended at $775 million with net leverage of 3.3x. First-quarter 2026 revenue guidance is $1.225–$1.240 billion, assuming approximately $600 million of labor disruption revenue.
AMN Healthcare (NYSE: AMN) will hold a conference call to discuss fourth quarter and full year 2025 results and provide first quarter 2026 outlook on Thursday, February 19, 2026 at 5:00 p.m. ET. The company expects to issue its earnings news release after market close at approximately 4:15 p.m. ET the same day.
A live webcast and replay will be available on AMN Healthcare’s investor relations website, and live telephone participation requires registration to receive a PIN and dial-in instructions. Contact information for investor relations is provided for additional assistance.
AMN Healthcare (NYSE: AMN) reported Q3 2025 revenue of $634.5M (down 8% YoY) and adjusted EBITDA of $57.5M (down 22% YoY). GAAP net income was $29.3M or $0.76 per diluted share; adjusted diluted EPS was $0.39 (down 36% YoY). Cash from operations was $23M and proceeds from the sale of Smart Square were $65M, enabling repayment of the revolver balance.
The company completed a $400M 6.50% senior notes issuance due 2031, amended its revolver to $450M maturing 2030, and redeemed $500M of 2027 notes. Q4 2025 guidance: consolidated revenue $715–$730M, adjusted EBITDA margin 6.8%–7.3% with assumed labor disruption revenue ~ $100M.
AMN Healthcare (NYSE: AMN) will report third quarter 2025 results and discuss fourth quarter 2025 outlook on Thursday, November 6, 2025. The company expects to issue an earnings news release after market close at approximately 4:15 p.m. ET, followed by a conference call at 5:00 p.m. ET.
A live webcast and replay will be available on AMN Healthcare’s investor relations website. Investors may join the call by telephone after registering with a valid email to receive a PIN and dial-in instructions.
AMN Healthcare (NYSE: AMN) has announced the pricing of $400.0 million senior unsecured notes due 2031 with an interest rate of 6.500% per annum. The notes will be issued at 100.0% of face value and guaranteed by the company's affiliates that guarantee its credit facilities.
The company plans to use the proceeds, along with cash on hand and borrowings under a new revolving facility, to redeem all $500.0 million of its 4.625% senior notes due 2027. The redemption is scheduled for October 22, 2025, subject to the successful completion of the 2031 Notes offering, which is expected to close on October 6, 2025.
AMN Healthcare, as the leader in healthcare total talent solutions, served nearly 15 million patients at more than 2,100 healthcare systems in 2024, including 87% of top healthcare systems nationwide.